Mode
Text Size
Log in / Sign up

Retrospective cohort identifies risk factors and predicts postherpetic neuralgia risk in patients with herpes zosterNew model predicts nerve pain risk following shingles outbreaks in patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider this retrospective tool for early risk stratification in herpes zoster, noting observational associations.

This retrospective cohort study included 846 patients with herpes zoster from the Affiliated Hospital of Putian University and Zhangzhou Affiliated Hospital of Fujian Medical University. The population was divided into 627 training and 219 validation subsets. The primary objective was the prediction of postherpetic neuralgia risk following herpes zoster onset. Key risk factors identified included age, timing of antiviral therapy, acute pain severity, prodromal phase pain, and diabetes.

The study utilized an XGBoost model to assess prediction performance. PHN incidence was 19.0% in the training set and 22.8% in the validation set. Specifically, 119 of 627 training patients and 50 of 219 validation patients developed the condition. Model performance metrics included accuracy, sensitivity, F1 score, calibration, and clinical utility.

The XGBoost model AUC was 0.826 in the training cohort and 0.840 in the validation cohort. The 95%CI was 0.786–0.866 for training and 0.784–0.896 for validation. Follow-up duration was not reported. Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported.

Limitations include the retrospective observational design and model validation limited to two specific cohorts. The causality note indicates an observational association where risk factors were identified via feature selection, but causation was not established. Important practice relevance currently suggests this tool can assist clinicians in early risk stratification and guide personalized management for patients with HZ.

Scientists looked at medical records from 846 people who had shingles to see who might develop long-term nerve pain. This condition is called postherpetic neuralgia. The researchers wanted to find a way to predict which patients are at higher risk. They used a computer model to analyze the data from two hospitals.

The study found that about one in five patients developed nerve pain. The computer model performed well in identifying these patients. It highlighted specific factors like older age, having diabetes, and how severe the pain was when the shingles first started. The timing of antiviral treatment also mattered.

It is important to remember that this research is observational. This means it looks at past data without changing treatments. The study team noted that they cannot prove these factors cause the pain. They also mentioned the model was only tested on patients from two specific hospitals.

This tool helps doctors plan care but is not a final diagnosis. It can assist clinicians in early risk stratification. Patients should discuss their personal risk factors with their healthcare provider. This work is a step toward better management but needs more research to confirm results.

What this means for you:
Researchers identified risk factors for nerve pain after shingles, but results need more study.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectivePostherpetic neuralgia (PHN) is a debilitating complication of herpes zoster (HZ), and early identification of high-risk patients is crucial for timely intervention. This study aimed to develop and validate machine learning models to predict the risk of developing PHN following HZ onset.MethodsA retrospective analysis of two prospective cohorts was performed. The training cohort comprised 627 patients from the Affiliated Hospital of Putian University, and an independent external validation cohort included 219 patients from Zhangzhou Affiliated Hospital of Fujian Medical University. Least Absolute Shrinkage and Selection Operator (LASSO) regression and the Boruta algorithm were used for feature selection. Ten ML models were constructed and evaluated based on metrics including the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, F1 score, calibration, and clinical utility. The optimal model was further interpreted using SHapley Additive exPlanations (SHAP).ResultsThe incidence of PHN was 19.0% (119 of 627) in the training cohort and 22.8% (50 of 219) in the validation cohort. Subsequently, five key risk factors were identified. Among the 10 models, XGBoost exhibited the best comprehensive performance, with an AUC of 0.826 (95%CI: 0.786–0.866) in the training cohort and 0.840 (95%CI: 0.784–0.896) in the validation cohort. SHAP analysis revealed that age was the most important predictor, followed by timing of antiviral therapy, acute pain severity, prodromal phase pain, and diabetes.ConclusionThe XGBoost model based on five clinically accessible factors effectively predicts the risk of PHN. This tool can assist clinicians in early risk stratification and guide personalized management for patients with HZ.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.